Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)


Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment

Temple University Hospital’s Participation in National Cardiogenic Shock Study Featured in the Media

View All News

Temple University Hospital is one of 65 sites enrolled in the National Cardiogenic Shock Initiative (NationalCSI) study, which showed that 72 percent of patients with cardiogenic shock survived their heart attack when treated with a specific protocol offered at selected sites around the country. The trial results were announced on May 21 at the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions. Typical survival rate from the complication has historically been around 50 percent. Brian O’Neill, MD, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University, is leading the efforts at Temple University Hospital. CNBNews reported on the results.